Evidence map›Paper›PMID 33938501›Full record

SynthesisPsychosomatic medicine2021

Major Depression and Survival in People With Cancer.

Jane Walker, Amy Mulick, Nicholas Magill, Stefan Symeonides, Charlie Gourley, Katy Burke, Aurelien Belot, Matteo Quartagno, Maike van Niekerk, Mark Toynbee and 2 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Psychosomatic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 6 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 6 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Article
  8. Article
  9. Depression and increased cancer risk: a 10-year population-based cohort study.Social psychiatry and psychiatric epidemiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jane WalkerFrom Psychological Medicine Research (Walker, Burke, van Niekerk, Toynbee, Sharpe), University of Oxford Department of Psychiatry, Warneford Hospital, Oxford; Department of Non-Communicable Disease Epidemiology (Mulick, Quartagno), London School of Hygiene and Tropical Medicine; Department of Medical Statistics (Magill, Belot, Frost), London School of Hygiene and Tropical Medicine, London; and Cancer Research UK Edinburgh Centre (Symeonides, Gourley), University of Edinburgh, Edinburgh, United Kingdom.
Amy Mulick
Nicholas Magill
Stefan Symeonides
Charlie Gourley
Katy Burke
Aurelien Belot
Matteo Quartagno
Maike van Niekerk
Mark Toynbee
Chris Frost
Michael Sharpe
Transnational Press LondonScience Oxford · GB

Funding

Cancer Research UK 18525Cancer Research UK 29018Cancer Research UK C5547/A7375Medical Research Council MC_UU_00004/07
6 · The paper itself

Abstract

objectiveThe question of whether depression is associated with worse survival in people with cancer remains unanswered because of methodological criticism of the published research on the topic. We aimed to study the association in a large methodologically robust study.

methodsWe analyzed data on 20,582 patients with breast, colorectal, gynecological, lung, and prostate cancers who had attended cancer outpatient clinics in Scotland, United Kingdom. Patients had completed two-stage screening for major depression as part of their cancer care. These data on depression status were linked to demographic, cancer, and subsequent mortality data from national databases. We estimated the association of major depression with survival for each cancer using Cox regression. We adjusted for potential confounders and interactions between potentially time-varying confounders and the interval between cancer diagnosis and depression screening, and used multiple imputation for missing depression and confounder data. We pooled the cancer-specific results using fixed-effects meta-analysis.

resultsMajor depression was associated with worse survival for all cancers, with similar adjusted hazard ratios (HRs): breast cancer (HR = 1.42, 95% confidence interval [CI] = 1.15-1.75), colorectal cancer (HR = 1.47, 95% CI = 1.11-1.94), gynecological cancer (HR = 1.36, 95% CI = 1.08-1.71), lung cancer (HR = 1.39, 95% CI = 1.24-1.56), and prostate cancer (HR = 1.76, 95% CI = 1.08-2.85). The pooled HR was 1.41 (95% CI = 1.29-1.54, p < .001, I2 = 0%). These findings were not materially different when we only considered the deaths (90%) that were attributed to cancer.

conclusionsMajor depression is associated with worse survival in patients with common cancers. The mechanisms of this association and the clinical implications require further study.

Indexed as

Breast NeoplasmsMajor Depressive DisorderDepressionHumansMaleProportional Hazards ModelsUnited Kingdom

Identifiers

PMID33938501
PMCPMC7614901
OpenAlexW3158985447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.